Delivery Order SPE2DB20D7059-SPE2DB25FGSJ9
- Not listed
- The Defense Logistics Agency awarded a $2,759.60 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for TYPHIM VI 25 MCG/0.5 ML syringes. This is a firm fixed price, competitively awarded contract with an ultimate completion date of August 25, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $37,836.27 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $10,531.20 with a completion date of September 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes in 0.5 ML quantities, with a contract ceiling value of $6,899.00. This is a firm fixed-price delivery order with an ultimate completion date of September 5, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $55,192 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $13,645.30 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This competitively awarded, firm fixed-price contract is scheduled for completion by July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,379.80 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical supply transaction within the...
- The Defense Logistics Agency (DLA) awarded a $3,449.50 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on September 12, 2025, with completion scheduled for September 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger federal contract vehicle. The order will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $6,899.00, with completion due by August 1, 2025. This non-set-aside, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a $8,140.82 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for TYPHIM VI 25 MCG/0.5 ML syringes. This non-competitive delivery order, classified as a Firm Fixed Price contract, will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. The award represents a routine pharmaceutical supply transaction executed through AmerisourceBergen's existing contract...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FGSJ9Delivery Order
The Defense Logistics Agency awarded a $1,379.80 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. The contract represents a firm fixed price delivery order with an ultimate completion date of September 19, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in Conshohocken, PA 19428. This delivery order was issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including support to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The current delivery order for the TYPHIM VI vaccine represents a routine execution of this broader pharmaceutical supply agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/18/25 |